Action 2796 PHARMARISE HOLDINGS CORPORATION
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Pharmarise Holdings Corporation

Actions

2796

JP3802320006

Marché Fermé - Japan Exchange
Autres places de cotation
 08:00:00 26/04/2024 		Varia. 5j. Varia. 1 janv.
639 JPY -2,59 % Graphique intraday de Pharmarise Holdings Corporation -1,54 % -3,18 %
11/04 Le bénéfice attribuable de Pharmarise Holdings en baisse de 15 % au cours des neuf mois de l'exercice, en raison de l'augmentation des dépenses à la suite de la fusion et de l'acquisition. MT
10/04 Pharmarise Holdings Corporation révise ses prévisions de bénéfices consolidés pour l'exercice financier se terminant le 31 mai 2024 CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Pharmarise Holdings’ Attributable Profit Down 15% in Fiscal Nine Months on Higher Expenses Following M&A
Pharmarise Holdings Corporation Revises Consolidated Earnings Guidance for the Fiscal Year Ending May 31, 2024
Tranche Update on Pharmarise Holdings Corporation's Equity Buyback Plan announced on January 11, 2024.
Pharmarise Holdings Corporation announces an Equity Buyback for 1,416,800 shares, representing 12.07% for ¥1,032 million.
Pharmarise's Fiscal H1 Attributable Profit Soars as Net Sales Rise
Pharmarise Holdings Corporation authorizes a Buyback Plan.
Pharmarise Holdings Corporation entered into stock transfer agreement to acquire GOOD AID Inc. from Kotoshino Co., Ltd. and Yuta Hattori.
Pharmarise Holdings Corporation Provides Consolidated Earnings Guidance for the Fiscal Year Ending May 31, 2024
Pharmarise Holdings Corporation Provides Dividend Guidance for the Fiscal Year Ending May 31, 2024
Pharmarise Holdings Corporation Provides Consolidated Earnings Guidance for the Six Months and Full Year of Fiscal Year Ending May 31, 2024
Pharmarise Holdings Corporation acquired Nine Dispensing Pharmacies in Tokyo, Niigata, and Fukushima.
Pharmarise Holdings Corporation Provides Dividend Guidance for the Fiscal Year Ending May 31, 2024
Pharmarise Holdings Corporation Announces Commemorative Dividend for the Fiscal Year Ending May 31, 2024
Pharmarise Holdings Corporation Declares Dividend for the Fiscal Year Ending May 31, 2023, Payable on August 31, 2023
Pharmarise Holdings Corporation Provides Consolidated Earnings Guidance for the Six Months and Full Year of Fiscal Year Ending May 31, 2024
Pharmarise Logs 35% Drop in FY23 Nine-month Profit on Higher Utility Expenses, Lower Drugstore Sales
Pharmarise Holdings Corporation Provides Consolidated Earnings Guidance for the Fiscal Year Ending May 31, 2023
Pharmarise Holdings Corporation Provides Dividend Guidance for the Fiscal Year Ending May 31, 2023
Pharmarise Holdings Corporation entered into basic agreement to acquire Two Dispensing Pharmacies in Mie Prefecture.
Pharmarise Holdings Corporation Provides Consolidated Earnings Guidance for the Full Year of Fiscal Year Ending May 31, 2023
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action 2796
  4. Actualités Pharmarise Holdings Corporation
  5. Autres langues